Literature DB >> 28872418

Pregnancy planning preferences among people and couples affected by human immunodeficiency virus: Piloting a discrete choice experiment.

Mona Loutfy1,2, V Logan Kennedy1, Morvarid Sanandaji1, Fatimatou Barry1, Fanta Ongoiba3, Marvelous Muchenje4, Wangari Tharao4, Dean A Regier5,6.   

Abstract

Decision-making related to pregnancy planning is complex and human immunodeficiency virus (HIV) may further complicate the process. With increasing rates of pregnancy among individuals affected by HIV, the need to understand decision-making is imperative. The primary objectives of this pilot study were to confirm the feasibility of using discrete choice experimentation (DCE) to elicit an understanding of this process and to determine the acceptability of the choice factors that were included in two novel DCEs, while gathering a preliminary understanding of preference. The choice attributes were risk of vertical HIV transmission, risk of horizontal HIV transmission, cost, probability of conception, method of conception, and travel time. Thirteen respondents completed a DCE for serodiscordant couples in which the female partner was HIV-positive, and 12 respondents completed a DCE for seroconcordant couples. All respondents' utility for an increased chance of a successful pregnancy was positive and statistically significant. In the serodiscordant dyads, the attributes of risk of horizontal transmission, risk of vertical transmission, a 5-h travel time to clinic, and cost were significantly associated with decreased utility. In the seroconcordant dyads, only the attributes of chance of risk of vertical transmission and cost were significantly associated with decreased utility. The serodiscordant dyads preferred home insemination with a syringe and the seroconcordant couples preferred conception methods within fertility clinics, over condomless sex with timed ovulation. On average, participants were willing to pay more for greater chance of conception and less willing to pay for increased risk of transmission. Couples affected by HIV are willing to participate in a DCE and the attributes that were included all seem relevant except risk of vertical transmission. There are various real-life trade-offs that are made during pregnancy planning with HIV and better understanding of these can be useful for clinicians during preconception counseling.

Entities:  

Keywords:  Pregnancy planning; discrete choice experiment; human immunodeficiency virus

Mesh:

Year:  2017        PMID: 28872418     DOI: 10.1177/0956462417728188

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  6 in total

1.  Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States.

Authors:  Ashley A Leech; James F Burgess; Meg Sullivan; Wendy Kuohung; Michal Horný; Mari-Lynn Drainoni; Cindy L Christiansen; Benjamin P Linas
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

2.  Implementing a Pre-Exposure Prophylaxis Intervention for Safer Conception among HIV Serodiscordant Couples: Recommendations for Health Care Providers.

Authors:  Mari-Lynn Drainoni; Dea L Biancarelli; Ashley A Leech; Meg Sullivan; Angela R Bazzi
Journal:  J Health Dispar Res Pract       Date:  2018

3.  HIV Pre-Exposure Prophylaxis for Conception Among HIV Serodiscordant Couples in the United States: A Cohort Study.

Authors:  Ashley A Leech; Dea Biancarelli; Erika Aaron; Emily S Miller; Jenell S Coleman; Peter L Anderson; Hervette Nkwihoreze; Brianne Condron; Meg Sullivan
Journal:  AIDS Patient Care STDS       Date:  2020-07       Impact factor: 5.078

4.  What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment.

Authors:  Elena Keller; Willings Botha; Georgina M Chambers
Journal:  Appl Health Econ Health Policy       Date:  2022-09-29       Impact factor: 3.686

5.  Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.

Authors:  Alexandra M Minnis; Erica N Browne; Marco Boeri; Kawango Agot; Ariane van der Straten; Khatija Ahmed; Rachel Weinrib; Carol Mansfield
Journal:  J Acquir Immune Defic Syndr       Date:  2019-04-01       Impact factor: 3.731

6.  Eliciting Preferences for HIV Prevention Technologies: A Systematic Review.

Authors:  S Wilson Beckham; Norah L Crossnohere; Margaret Gross; John F P Bridges
Journal:  Patient       Date:  2020-12-15       Impact factor: 3.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.